Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
The Schmooze

Gloria Steinem Hates Lipstick But Made A Lip Balm To Benefit Incarcerated Women

“I never wear lipstick,” Gloria Steinem told Vogue. “But I can support a lip balm.”

Steinem is a human rights icon, a celebrated writer, and a living hero of history. She also happens to be a paragon of gorgeous style. What’s a girl to do?

In Steinem’s case, the answer is a genius workaround — she partnered with Lipstick Lobby to create a sheer, chicly-packaged balm for which 100% of profits will go to a non-profit organization that helps incarcerated and formerly incarcerated women. “In the Clear,” the vitamin E-based nourishing lip treatment Steinem developed with social-justice beauty company Lipstick Lobby, will retail for $19. All of the net profits from “In The Clear” will go to the UnPrison Project — a non-profit created by Deborah Jiang-Stein which works to provide incarcerated women — particularly mothers — with the skills and empowerment they will need for life after prison and to avoid re-incarceration. The program, which teaches skills like literacy and career-preparedness, has reached over 20,000 women in US prisons. That’s 10% of all women in American prisons.

“Corporations are making money from prisons that charge as much per prisoner as it would take to send a student to Harvard, even though these offenses are minor,” Steinem told Vogue, calling the US prison system a “scandal and shame.”

But there’s no shame in marrying retail therapy and justice work — unlike when other companies offer a tiny fraction of sale profits to a cause, Lipstick Lobby really will give all net profits directly to the UnPrison Project. Like Gloria says: that’s a lip balm we can support.

Jenny Singer is the deputy lifestyle editor for the Forward. You can reach her at [email protected] or on Twitter @jeanvaljenny

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.